Autres langues Camurus AB

Actions

CAMX

SE0007692850

Temps réel estimé Cboe Europe Autres places de cotation 16:34:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
601,5 ^SEK	+1,35%		+3,00%	+11,80%

25/06	Camurus annonce la publication dans JAMA Network Open d'une nouvelle analyse post hoc d'une étude de phase 3 randomisée, en double aveugle, d'une durée de 24 semaines	CI
31/05	AVIS D'ANALYSTES DU JOUR : Capgemini, Saint-Gobain, Neoen, Derichebourg, Lonza, Ahold, Richemont...

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Change in number of shares and votes in Camurus	07:01
New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl	25/06
Camurus Announces the Publication in JAMA Network Open of A New Post H Holes Analysis from A 24-Week Randomized, Double-Blind, Phase 3 Study	25/06
Exercise of Camurus' employee stock options program 2021/2024	12/06
Sandberg Development has sold 1.3 million shares in Camurus	11/06
OPINIONI DEGLI ANALISTI DEL GIORNO : Italgas,Telecom Italia, Swisscom, Generali, Centrica, Buzzi, Lonza, Ahold, Sacyr, Richemont...	31/05
OPINIONES DE LOS ANALISTAS DEL DÍA : Aedas, Bbva, Sabadell, Cellnex, Fluidra, Lonza, Ahold, Sacyr, Richemont...	31/05
Camurus' Board of Directors exercises authorization for repurchase of shares for the purpose of securing the company's commitments under the Performance Share Plan 2024/2027	30/05
Camurus to present at Jefferies 2024 Healthcare Conference New York	28/05
Camurus' Rare Growth Disorder Drug Accepted for Review in EU	23/05
Camurus receives EMA acceptance of MAA filing for octreotide SC depot (CAM2029) for the treatment of acromegaly	23/05
Camurus Receives EMA Acceptance of MAA Filing for Octreotide SC Depot for the Treatment of Acromegaly	23/05
Camurus : AGM minutes 2024	13/05
Resolutions at the annual general meeting 2024 in Camurus	08/05
Camurus' Interim Report January-March 2024	08/05
Camurus AB Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Certain Shares of Camurus AB are subject to a Lock-Up Agreement Ending on 17-APR-2024.	17/04
Notice of annual general meeting 2024 in Camurus (publ)	02/04
Camurus AB Announces Board Resignations	02/04
Camurus Annual Report for 2023	28/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Camurus AB

Actions

CAMX

SE0007692850

Autres langues

Filtres